An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy

Eur J Neurosci. 2004 Jun;19(11):3048-58. doi: 10.1111/j.0953-816X.2004.03392.x.

Abstract

Neuronal subthreshold excitability and firing behaviour are markedly influenced by the activation and deactivation of the somato-dendritic hyperpolarization-activated cation current (Ih). Here, we evaluated possible contributions of Ih to hyperexcitability in an animal model of absence seizures (WAG/Rij rats). We investigated pyramidal neurons of the somatosensory neocortex, the site of generation of spike-wave discharges. Ih-mediated functions in neurons from WAG/Rij rats, Wistar rats (sharing the same genetic background with WAG/Rij, but less epilepsy-prone) and ACI rats (an inbred strain, virtually free of seizures) were compared. We complemented whole-cell recordings from layer 2-3 pyramidal neurons with immunohistochemistry, Western blot and RT-PCR analysis of the h-channel subunits HCN1-4. The fast component of Ih activation in WAG/Rij neurons was significantly reduced (50% reduction in the h-current density) and four times slower than in neurons from nonepileptic Wistar or ACI rats. The results showing decreases in currents corresponded to a 34% reduction in HCN1 protein in the WAG/Rij compared to the Wistar neocortex, but HCN1 mRNA showed stable expression. The other three Ih subunit mRNAs and proteins (HCN2-4) were not affected. The alterations in Ih magnitude and kinetics of gating in WAG/Rij neurons may contribute to augmented excitatory postsynaptic potentials, the increase in their temporal summation and the facilitation of burst firing of these neurons because each of these effects could be mimicked by the selective Ih antagonist ZD 7288. We suggest that the deficit in Ih-mediated functions may contribute to the development and onset of spontaneously occurring hyperexcitability in a rat model of absence seizures.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • Animals
  • Blotting, Western / methods
  • Brain / anatomy & histology
  • Brain / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Radiation
  • Drug Interactions
  • Electric Impedance
  • Epilepsy, Absence / physiopathology*
  • Excitatory Amino Acid Antagonists / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / genetics
  • Immunohistochemistry / methods
  • In Situ Hybridization / methods
  • In Vitro Techniques
  • Ion Channel Gating / drug effects
  • Ion Channels / drug effects
  • Ion Channels / genetics
  • Ion Channels / physiology*
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / genetics
  • Neocortex / physiopathology*
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology*
  • Patch-Clamp Techniques / methods
  • Potassium Channels / metabolism
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiopathology*
  • Pyrimidines / pharmacology
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Inbred Strains
  • Rats, Wistar
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Species Specificity

Substances

  • Excitatory Amino Acid Antagonists
  • Ion Channels
  • Nerve Tissue Proteins
  • Potassium Channels
  • Pyrimidines
  • RNA, Messenger
  • ICI D2788
  • 2-Amino-5-phosphonovalerate